Evidence map›Paper›PMID 39211347›Full record

ArticleKidney medicine2024

Successful Kidney Transplant from Donors with Sickle Cell Disease: A Case Series of Six Transplants.

Prathap Kumar Simhadri, Felicitas Koller, Praise Matemavi, Mark Truman Earl, Deepak Chandramohan, Pradeep K Vaitla

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Prathap Kumar SimhadriDivision of Nephrology, Advent Health/FSU College of Medicine, Daytona Beach, FL.
Felicitas KollerDivision of Transplant and Hepatobiliary Surgery, University of Mississippi Medical Center, Jackson, MS.
Praise MatemaviDivision of Transplant and Hepatobiliary Surgery, University of Mississippi Medical Center, Jackson, MS.
Mark Truman EarlDivision of Transplant and Hepatobiliary Surgery, University of Mississippi Medical Center, Jackson, MS.
Deepak ChandramohanDivision of Nephrology, University of Alabama at Birmingham, Birmingham, AL.
Pradeep K VaitlaDivision of Transplant and Hepatobiliary Surgery, University of Mississippi Medical Center, Jackson, MS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People with sickle cell disease experience a high incidence of chronic kidney disease and end-stage kidney disease, secondary to tubular and glomerular effects of vaso-occlusion-induced hypoxia. Because of concerns of suboptimal kidney function, sickle cell donors are usually not considered for kidney donation, even if the rest of the parameters are acceptable for organ donation. A significant gap exists between the number of organ donors and the number of candidates waiting for a kidney transplant in the United States. To bridge the gap, we need to consider using nontraditional donors. We report kidney transplant outcomes in 6 recipients from 4 sickle cell kidney donors. Intracranial hemorrhage and sepsis were the causes of the death in donors, and no donor was in sickle cell crisis at the time of donation. None of the recipients experienced delayed graft function, and all recipients achieved excellent allograft function. The earliest allograft failure was at 27 months in a recipient who developed early acute rejection, while the longest follow-up was 10 years with adequate kidney function. In conclusion, given the shortage of kidneys for transplantation and demonstrated good outcomes, we propose that kidneys from sickle cell donors can be safely used.

Indexed as

kidney transplantationoutcomessickle cellSickle cell diseasesickle cell donorstransplantation

Identifiers

PMID39211347
PMCPMC11359733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.